Guanhao Biotech Co.,Ltd. (SHE:300238)
11.28
-0.11 (-0.97%)
Oct 14, 2026, 12:54 PM CST
Guanhao Biotech Revenue
Guanhao Biotech had revenue of 81.07M CNY in the quarter ending June 30, 2026, a decrease of -23.57%. This brings the company's revenue in the last twelve months to 361.40M, down -7.01% year-over-year. In the year 2025, Guanhao Biotech had annual revenue of 387.75M with 2.72% growth. That makes Guanhao Biotech the 27,366th largest company in the world by revenue and 4,755th in China.
Revenue (ttm)
361.40M
Revenue Growth
-7.01%
P/S Ratio
8.66
Revenue / Employee
675.51K
Employees
535
Market Cap
3.10B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 387.75M | 10.27M | 2.72% |
| Dec 31, 2024 | 377.48M | -26.70M | -6.60% |
| Dec 31, 2023 | 404.18M | 26.89M | 7.13% |
| Jan 1, 2023 | 377.29M | -111.70M | -22.84% |
| Jan 1, 2022 | 488.98M | 52.02M | 11.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Baolingbao Biology | 2.85B |
| Xiangxue Pharmaceutical | 1.48B |
| Qingdao Vland Biotech INC. | 1.42B |
| Beijing Kawin Technology Share-Holding | 1.23B |
| Shanghai Universal Biotech | 1.15B |
| Pulike Biological Engineering | 1.02B |
| Zhejiang East Asia Pharmaceutical | 990.47M |
| Zhejiang Shouxiangu Pharmaceutical | 616.54M |